期刊
ADVANCED FUNCTIONAL MATERIALS
卷 21, 期 22, 页码 4211-4218出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adfm.201100853
关键词
-
类别
资金
- World-Class University (WCU)
- Ministry of Education, Science and Technology (MEST) of Korea [R31-10026]
- Institute of Medical Sytems Engineering
Novel paclitaxel-loaded polymer nanoparticles were developed for circumventing multidrug resistance (MDR) of malignant cancerous diseases, which is an unsolved clinical problem in cancer chemotherapy. In many cases, MDR is due to the intrinsic or acquired expression of an efflux pump, the P-170 glycoprotein (P-gp). By encapsulating paclitaxel in a water-soluble and biocompatible synthetic polyampholyte using a solid-state reaction the highly water-soluble paclitaxel-loaded nanoparticles are formed. The resulting paclitaxel nanoparticles with an average diameter of 250 nm show a significant reversal of chemoresistance in the drug-resistant variants (MCF7/ADR, MT3/ADR) by a factor of 100 or more. The novel paclitaxel nanoparticles enter MDR breast cancer cells by adsorptive endocytosis bypassing the P-gp, preventing the efflux of paclitaxel and thus restoring the anti-proliferative effect of paclitaxel.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据